Explores the opportunities and challenges of genomics in biotechnologies and biomedicine, focusing on the human genome, personalized medicine, and the genomics of sudden cardiac death.
Covers the historical development of genomics, from Sanger sequencing to high-throughput technologies and cost reductions, highlighting the impact of key players like Craig Venter.
